Skip to content
Search

Capital at risk. Past performance is not a reliable indicator of current or future results and should not be the sole factor of consideration when selecting a product or strategy.

The listed funds are not an exhaustive list of funds available. Visit www.funds.troweprice.com to see the full range of funds offered by T. Rowe Price, including those that consider environmental and social characteristics as part of their investment process.  For up to date information regarding any T. Rowe Price fund's investment strategy, please see the relevant fund KID and prospectus. 

SICAV
Global Growth Equity Fund
An actively managed, growth-oriented portfolio of typically 150-200 companies, seeking to harness the best ideas of our global research team. The fund offers broad exposure to the global equity universe, both developed and emerging markets, investing in around 30 countries.
ISIN LU0382933116
View more information on risks
FACTSHEET
KID
SFDR DISCLOSURE
31-Oct-2024 - Scott Berg, Portfolio Manager,
We are now in a different part of the interest rate cycle with the US Federal Reserve cutting rates, which could create new opportunities as we see different stock winners and losers as a result. We are encouraged by the resiliency of our portfolio and are optimistic heading into the latter part of the year.

Overview
Strategy
Fund Summary
We seek to invest in high-quality, durable businesses with sustainable growth prospects. We look for companies in attractive industries with improving fundamentals and potential for above-average and sustainable rates of earnings growth, when we believe valuations offer us high conviction, upside potential. The manager is not constrained by the fund's benchmark, which is used for performance comparison purposes only.
Performance - Net of Fees

Past performance is not a reliable indicator of future performance.

31-Oct-2024 - Scott Berg, Portfolio Manager,
Global equities sold off in October. Markets were pressured by strong economic data in the US diminishing expectations for more interest rate cuts, signs of deceleration in artificial intelligence demand, China stimulus scepticism, and geopolitical uncertainty. A strengthening US dollar versus other major currencies also weighed on returns for US-based investors. Within the portfolio, stock selection in financials, coupled with an overweight position, contributed the most to relative returns. A large Latin American digital banking platform rebounded from September following the stock’s sell-off in the previous month. We have high conviction in the company and think its highly disruptive digital banking platform can continue to gain share and even scale internationally, which provides it with a long growth runway. Conversely, stock selection in health care hurt relative results. Shares of a leading global bio-analysis company specialising in food, environmental, pharmaceutical products, and clinical diagnostics testing sold off after the company reported mixed earnings results, with worse-than-expected core organic growth, although management raised margin guidance while earnings and free cash flow guidance remained unchanged. We continue to think the company has a one-of-a-kind platform and should deliver strong, durable growth over the long term.
31-Dec-2023 - Scott Berg, Portfolio Manager,
We have an overweight position in financials. We currently have exposure to what we believe are high-quality US banks but are meaningfully underweight European and Japanese banks that broadly have more negative credit exposure. We have more exposure to insurance companies than we have typically had in the past, as an improving pricing environment and better yields on portfolio investments have created a positive near- and medium-term setup. We continue to own several emerging market financials we believe are undervalued and underappreciated and have exposure to high-quality alternative asset managers and leading capital markets companies.

Past performance is not a reliable indicator of future performance.

The Funds are sub-funds of the T. Rowe Price Funds SICAV, a Luxembourg investment company with variable capital which is registered with Commission de Surveillance du Secteur Financier and which qualifies as an undertaking for collective investment in transferable securities (“UCITS”). Full details of the objectives, investment policies and risks are located in the prospectus which is available with the key investor information documents and/or key information document (KID) in English and in an official language of the jurisdictions in which the Funds are registered for public sale, together with the articles of incorporation and the annual and semi-annual reports (together “Fund Documents”). Any decision to invest should be made on the basis of the Fund Documents which are available free of charge from the local representative, local information/paying agent or from authorised distributors. They can also be found along with a summary of investor rights in English at www.troweprice.com. The Management Company reserves the right to terminate marketing arrangements.

Hedged share classes (denoted by 'h') utilise investment techniques to mitigate currency risk between the underlying investment currency(ies) of the fund and the currency of the hedged share class.  The costs of doing so will be borne by the share class and there is no guarantee that such hedging will be effective.

Before deciding to invest in the fund, you should read the offering document/prospectus (including its investment objectives, policies and any risk warnings) which are available and may be obtained from any appointed distributors.

The specific securities identified and described in this website do not represent all of the securities purchased, sold, or recommended for the sub-fund and no assumptions should be made that the securities identified and discussed were or will be profitable.

A full list of the currently issued Share Classes including Distributing, Hedged, and Accumulating Categories may be obtained, free of charge and upon request, from the registered office of the Company.  

Benchmark: Investors may use the benchmark to compare the fund’s performance. The benchmark has been selected because it is similar to the investment universe used by the investment manager and therefore acts as an appropriate comparator. The investment manager is not constrained by any country, sector and/or individual security weightings relative to the benchmark and has complete freedom to invest in securities that do not form part of the benchmark.

Disclosure on Vendor Indices can be found here.